LAURA FIERKE: Open Payments
NPI 1821472440 · HONESDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,090 in 102 payments from 26 companies in 2025. Trend: 2023 $225 · 2024 $1,429 · 2025 $2,090
Food & beverage: $2,090
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $273 |
| Novartis Pharmaceuticals Corporation | 11 | $234 |
| UCB, Inc. | 10 | $191 |
| Lilly USA, LLC | 9 | $150 |
| Biogen, Inc. | 6 | $118 |
| TG Therapeutics, Inc. | 6 | $108 |
| Celgene Corporation | 5 | $104 |
| Neurocrine BioSciences, Inc. | 5 | $97 |
| Alexion Pharmaceuticals, Inc. | 5 | $92 |
| EMD Serono, Inc. | 4 | $86 |
Products named: KESIMPTA, UBRELVY, BRIUMVI, Leqembi, ZEPOSIA, INGREZZA, ULTOMIRIS, QULIPTA.
Industry payments across PA — which companies pay providers there.
